AXA’s Linden Thomson: You need a scientific background to be a biotech investor

Loading player...
Linden Thomson, manager of the Axa Framlington Biotech fund, speaks about the 'heavily momentum driven' biotech sector, and why Biden’s inflation reduction act could tighten R&D investment. 
1 Mar 2023 English United Kingdom Business · Investing

Other recent episodes

Ex-Aberdeen leader on why wealth firms can't ignore digital assets

As the world of traditional finance and digital assets converge, Duncan Moir, traded a long career at Aberdeen for a role in the digital frontier. In this episode, Moir explains why wealth managers who fail to integrate digital assets into portfolios risk being fundamentally left behind in the race for…
14 May 27 min

FCA on red tape cuts: This is just the start

Nick Hulme, head of advisers, wealth and pensions at the FCA, discusses why the regulator is not an 'amorphous blob', and what its growth initiatives will look like for firms in real time.
6 May 26 min